Counterfeit medicines are a global problem costing patient’s their health and the pharmaceutical industry and governmental organizations millions of dollars per year. Although there is no one preventative strategy, there are several measures that can be employed simultaneously to reduce the risk of fake medicines entering the pharmaceutical supply chain.
Scope
Overview of the prevalence and drivers of counterfeit medicines, examining the economic and health cost of fake medicines
Analysis of how counterfeit medicines enter the market, and strategies taken to tighten up supply chain security
Assessment of key anti-counterfeiting technologies employed by pharmaceutical manufacturers, supported by case study analysis
Examination of governmental and NGO based initiatives to improve regulation, legislation and enforcement of anti-counterfeiting protocols
Highlights
Incidents of counterfeit medicines are on the increase. However, reported figures only represent the tip of the iceberg, particularly in developing countries due to the insufficient anti-counterfeiting resources available
Parallel importation and online pharmacies are increasingly becoming the route of choice for counterfeiters to distribute fake medicines to patients on a global scale. Find out why, and what is being done to address these matters Currently, 2D-barcodes and radio frequency identification tagging (RFID) are the two most prominent track & trace technologies. However, with the FDA having no preference, which technologies will pharmaceutical companies opt for?
Reasons to Purchase
Identify the cause, prevalence and drivers of counterfeiting in the world today
Evaluate which anti-counterfeiting strategies are available, and which ones to adopt
Understand what anti-counterfeiting regulations and legislations will likely affect the pharmaceutical industry in the near future.
